A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Clinical trial NCT06183216 · COMPLETED

Trial details

NCT number: NCT06183216
Sponsor: Sinovac Research and Development Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infectious Disease

Start date: 2024-01-04
Primary completion: 2025-03-26
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.